TREATMENT AND PREVENTION OF BASAL-CELL CARCINOMA WITH ORAL ISOTRETINOIN

[1] BELISARIO JC, 1972, MELANOMA SKIN CANCER, P349

[2] BERGER H, 1981, RETINOIDS ADV BASIC, P435

[3] BOLLAG W, 1975, ACTA DERM-VENER S, V74, P163

[4] CASSIDY J, 1981, P AM ASSOC CANC RES, V22, P441

[5] CHEMOTHERAPY FOR METASTATIC BASAL-CELL CARCINOMA [J]. ARCHIVES OF DERMATOLOGY, 1983, 119 (01) : 44 - 50

[6] DENNERT G, 1984, RETINOIDS, V2, P373

[7] DIGIOVANNA JJ, 1987, J INVEST DERMATOL, V88, P485

[8] VERTEBRAL ABNORMALITIES ASSOCIATED WITH SYNTHETIC RETINOID USE [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 10 (05) : 817 - 823

[9] GUTHRIE TH, 1982, LARYNGOSCOPE, V92, P1298

[10] TREATMENT OF KERATOACANTHOMAS WITH ORAL 13-CIS-RETINOIC ACID [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (10) : 560 - 562

[1] BELISARIO JC, 1972, MELANOMA SKIN CANCER, P349

[2] BERGER H, 1981, RETINOIDS ADV BASIC, P435

[3] BOLLAG W, 1975, ACTA DERM-VENER S, V74, P163

[4] CASSIDY J, 1981, P AM ASSOC CANC RES, V22, P441

[5] CHEMOTHERAPY FOR METASTATIC BASAL-CELL CARCINOMA [J]. ARCHIVES OF DERMATOLOGY, 1983, 119 (01) : 44 - 50

[6] DENNERT G, 1984, RETINOIDS, V2, P373

[7] DIGIOVANNA JJ, 1987, J INVEST DERMATOL, V88, P485

[8] VERTEBRAL ABNORMALITIES ASSOCIATED WITH SYNTHETIC RETINOID USE [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 10 (05) : 817 - 823

[9] GUTHRIE TH, 1982, LARYNGOSCOPE, V92, P1298

[10] TREATMENT OF KERATOACANTHOMAS WITH ORAL 13-CIS-RETINOIC ACID [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (10) : 560 - 562